Fny Investment Advisers, LLC Revance Therapeutics, Inc. Transaction History
Fny Investment Advisers, LLC
- $194 Million
- Q4 2024
A detailed history of Fny Investment Advisers, LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 477,823 shares of RVNC stock, worth $1.23 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
477,823
Previous 183,500
160.39%
Holding current value
$1.23 Million
Previous $952,000
52.52%
% of portfolio
0.75%
Previous 0.46%
Shares
8 transactions
Others Institutions Holding RVNC
# of Institutions
226Shares Held
82.9MCall Options Held
680KPut Options Held
896K-
Black Rock Inc. New York, NY8.57MShares$22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.73MShares$14.7 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.78MShares$12.3 Million0.0% of portfolio
-
Fil LTD Hamilton, D04.19MShares$10.8 Million0.01% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ4.16MShares$10.7 Million0.49% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...